These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17132961)

  • 1. In search of the molecular basis of memory loss in Alzheimer disease.
    Ashe KH
    Alzheimer Dis Assoc Disord; 2006; 20(4):200-1. PubMed ID: 17132961
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease.
    Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT
    Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. proBDNF Accelerates Brain Amyloid-β Deposition and Learning and Memory Impairment in APPswePS1dE9 Transgenic Mice.
    Chen J; Zhang T; Jiao S; Zhou X; Zhong J; Wang Y; Liu J; Deng J; Wang S; Xu Z
    J Alzheimers Dis; 2017; 59(3):941-949. PubMed ID: 28697556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.
    Choi IS; Lee YJ; Choi DY; Lee YK; Lee YH; Kim KH; Kim YH; Jeon YH; Kim EH; Han SB; Jung JK; Yun YP; Oh KW; Hwang DY; Hong JT
    J Alzheimers Dis; 2011; 27(1):127-41. PubMed ID: 21799245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer's disease via regulation of β-secretase activity.
    Lee YJ; Choi DY; Lee YK; Lee YM; Han SB; Kim YH; Kim KH; Nam SY; Lee BJ; Kang JK; Yun YW; Oh KW; Hong JT
    J Alzheimers Dis; 2012; 29(3):677-90. PubMed ID: 22330831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease.
    Mancini S; Balducci C; Micotti E; Tolomeo D; Forloni G; Masserini M; Re F
    J Control Release; 2017 Jul; 258():121-129. PubMed ID: 28501671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
    España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
    Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes.
    Takeda S; Sato N; Uchio-Yamada K; Sawada K; Kunieda T; Takeuchi D; Kurinami H; Shinohara M; Rakugi H; Morishita R
    Proc Natl Acad Sci U S A; 2010 Apr; 107(15):7036-41. PubMed ID: 20231468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
    Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
    Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geniposide ameliorates cognitive deficits by attenuating the cholinergic defect and amyloidosis in middle-aged Alzheimer model mice.
    Zhao C; Zhang H; Li H; Lv C; Liu X; Li Z; Xin W; Wang Y; Zhang W
    Neuropharmacology; 2017 Apr; 116():18-29. PubMed ID: 27940040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer's disease transgenic mouse model.
    Fabbro S; Schaller K; Seeds NW
    J Neurochem; 2011 Sep; 118(5):928-38. PubMed ID: 21689108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
    Morin JP; Cerón-Solano G; Velázquez-Campos G; Pacheco-López G; Bermúdez-Rattoni F; Díaz-Cintra S
    J Alzheimers Dis; 2016; 51(1):69-79. PubMed ID: 26836189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroanatomical abnormalities in behaviorally characterized APP(V717F) transgenic mice.
    Dodart JC; Mathis C; Saura J; Bales KR; Paul SM; Ungerer A
    Neurobiol Dis; 2000 Apr; 7(2):71-85. PubMed ID: 10783292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological alteration & toxic molecular inductions leading to cognitive impairment & neurotoxicity in transgenic mouse model of Alzheimer's disease.
    Ahuja M; Buabeid M; Abdel-Rahman E; Majrashi M; Parameshwaran K; Amin R; Ramesh S; Thiruchelvan K; Pondugula S; Suppiramaniam V; Dhanasekaran M
    Life Sci; 2017 May; 177():49-59. PubMed ID: 28286225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model.
    Ding Y; Qiao A; Wang Z; Goodwin JS; Lee ES; Block ML; Allsbrook M; McDonald MP; Fan GH
    J Neurosci; 2008 Nov; 28(45):11622-34. PubMed ID: 18987198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
    Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
    Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated A beta and apolipoprotein E in A betaPP transgenic mice and its relationship to amyloid accumulation in Alzheimer's disease.
    Kuo YM; Crawford F; Mullan M; Kokjohn TA; Emmerling MR; Weller RO; Roher AE
    Mol Med; 2000 May; 6(5):430-9. PubMed ID: 10952022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-β 1-24 C-terminal truncated fragment promotes amyloid-β 1-42 aggregate formation in the healthy brain.
    Mazzitelli S; Filipello F; Rasile M; Lauranzano E; Starvaggi-Cucuzza C; Tamborini M; Pozzi D; Barajon I; Giorgino T; Natalello A; Matteoli M
    Acta Neuropathol Commun; 2016 Oct; 4(1):110. PubMed ID: 27724899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A butyrolactone derivative 3BDO alleviates memory deficits and reduces amyloid-β deposition in an AβPP/PS1 transgenic mouse model.
    Wei L; Yang H; Xie Z; Yang S; Yang H; Zhao C; Wang P; Xu S; Miao J; Zhao B; Bi J
    J Alzheimers Dis; 2012; 30(3):531-43. PubMed ID: 22451314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.